ArticleInternational journal of nanomedicine2020
Synthesis of Silver Nanoparticles Using a Novel Cyanobacteria
Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
64 citing papers in PubMed, 149 citations in OpenAlex.
- Article
- Microalgae-Mediated Nanotechnology for Sustainable Agriculture: Applications, Advances, and Future Prospects.International journal of molecular sciences · 2026Review
- Harnessing Tolypothrix sp. A-8 for biogenic synthesis of silver oxide nanoparticles (AgONPs) for multifunctional biomedical applications.Discover nano · 2026Article
- Antimicrobial and Cytotoxic Activities of Biogenic Nanoparticles Produced by Cyanobacteria.Chembiochem : a European journal of chemical biology · 2026Review
- Biogenic synthesis and characterization of antimicrobial, anti-inflammatory, antioxidant, and biocompatible iron oxide nanoparticles (FeONPs) using Arthrospira sp. Extract.Discover nano · 2026Article
- Evaluation of Antimicrobial, Antioxidant, and Cytotoxic Capabilities of Biosynthesized Silver Nanoparticles Assisted by the Hot Spring Originated Cyanobacterium Desikacharya sp. TPB-4 Crude Extract and Its Fractionated Compound, Caffeic Acid.Chemistry & biodiversity · 2026Article
- Repercussions of Symbiotic Bacteria Associated with Entomopathogenic Nematodes and Their Biogenic Silver Nanoparticles on Immune Responses at Root-Knot Nematode Suppression.Microorganisms · 2025Article
- Biosynthesis of silver and gold nanoparticles using cyanobacteria, their pharmaceutical and industrial applications.RSC advances · 2025Review
- Phytogenic Silver Nanoparticles Derived fromBioengineering (Basel, Switzerland) · 2025Article
- Article
- Photosynthetic Microorganisms and Biogenic Synthesis of Nanomaterials for Sustainable Agriculture.Nanomaterials (Basel, Switzerland) · 2025Review
- Bio-fabricated silver nanoparticles: therapeutic evaluation as a potential nanodrug against cervical and liver cancer cells.Discover nano · 2025Article
- AqueousNanomaterials (Basel, Switzerland) · 2025Article
- Sustainable production of microalgal nanoparticles through green synthesis towards cancer treatment.Frontiers in bioengineering and biotechnology · 2025Review
- The effect of plasma activated water on antimicrobial activity of silver nanoparticles biosynthesized by cyanobacterium Alborzia kermanshahica.BMC biotechnology · 2024Article
- Biogenic synthesis and characterization of antimicrobial, antioxidant, and antihemolytic zinc oxide nanoparticles from Desertifilum sp. TN-15 cell extract.Discover nano · 2024Article
- Antimicrobial Activity ofInternational journal of molecular sciences · 2024Article
- Evaluation of Cytotoxicity and Metabolic Profiling ofBiology · 2024Article
- Myco-fabricated silver nanoparticle by novel soil fungi from Saudi Arabian desert and antimicrobial mechanism.Scientific reports · 2024Article
- A review of microbes mediated biosynthesis of silver nanoparticles and their enhanced antimicrobial activities.Heliyon · 2024Review
4 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of multi drug-resistant (MDR) bacterial infections and cancer has necessitated the development and discovery of alternative eco-safe antibacterial and anticancer agents. Biogenic fabrication of metallic nanoparticles is an emerging discipline for production of nanoproducts that exert potent anticancer and antibacterial activity, and do not suffer from the limitations inherent in physiochemical synthesis methods. METHODOLOGY: In this study, we isolated, purified, and characterized a novel cyanobacteria extract (
resultsFormation of D-SNPs was indicated by a color change from pale yellow to dark brown. The peak of the surface plasmon resonance of the D-SNPs was at 421 nm. The XRD detected the crystallinity of D-SNPs. FTIR showed that polysaccharides and proteins may have contributed to the biofabrication of D-SNPs. Under SEM and TEM, the D-SNPs were spherical with diameter ranges from 4.5 to 26 nm. The D-SNPs significantly suppressed the growth of five pathogenic bacteria, and exerted cytotoxic effects against MCF-7, HepG2, and Caco-2 cancer cells with IC
conclusionThese findings showed for the first time the potentiality of novel cyanobacteria strain
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.